Shields Health Solutions Awards Two Resident Research Grants to Advance Health System Specialty Pharmacy
STOUGHTON, Mass.–(BUSINESS WIRE)–Shields Health Solutions (Shields), the premier specialty pharmacy accelerator in the country, is proud to award resident... Read more.
Private Equity Played an Outsize Role in the Growth of Inc. 5000 Awardees
BluWave’s Influence of Private Equity Report reveals that PE-backed companies on the 2023 Inc. 5000 Fastest Growing Companies list grew revenue by 480% and drove... Read more.
G-III Apparel Group Appoints Dana Perlman as its New Chief Growth and Operations Officer
NEW YORK–(BUSINESS WIRE)–G-III Apparel Group, Ltd. (NASDAQ: GIII) a global leader in fashion, with expertise in design, sourcing, and manufacturing,... Read more.
Gossamer Bio Appoints Bob Smith as Chief Commercial Officer
– Mr. Smith is a recognized leader in the commercialization of PAH products, most recently leading sotatercept US pre-launch activities at Merck – –... Read more.
Dialpad Named to Inc.’s 2023 Best in Business List for Contributions in AI & Data
Ai-Powered platform recognized on 4th annual list alongside 215 private companies putting purpose ahead of profit Dialpad for Good helps underrepresented founders... Read more.
Mainstreet Equity Corp Achieved 24 Years of Continued Double-digit Growth Across Key Metrics
CALGARY, Alberta–(BUSINESS WIRE)–In Q4 2023, Mainstreet posted our eighth consecutive quarter of double-digit, year-over-year growth across all key operating... Read more.
Ryder Signs First Customers to Multi-Year Electric Vehicle Contracts
Land ‘N’ Sea Distributing and Servientrega International Inc. Secure New Electric Cargo Vans as part of RyderElectric+ MIAMI–(BUSINESS WIRE)–Ryder... Read more.
RIBOMIC Phase I and II Data Published in the Eye: Full TOFU/RAMEN/TEMPURA Trial Results Demonstrate Clinical Proof of Concept of Umedaptanib Pegol in Exudative Age-Related Macular Degeneration (nAMD)
– Intravitreal umedaptanib pegol (an investigational anti-FGF2 aptamer) is safe, well tolerated, and effective in treatment naïve nAMD patients with striking... Read more.
Ermenegildo Zegna Group Unveils Updated Group Strategy Following Tom Ford Fashion Acquisition, and Strong Medium Term Financial Outlook
Group hosts second Capital Markets Day at the New York Stock Exchange and announces medium term financial outlook. Group aims for compounded average annual growth1... Read more.
Ferguson Reports First Quarter Results
Solid Performance with Full Year Guidance Unchanged First quarter highlights Sales decline of 2.8%, against a 16.6% prior year growth comparable. Operating margin... Read more.